Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...

Olumiant and other drugs like it had already been approved to treat autoimmune conditions like rheumatoid arthritis, but used off-label for alopecia.

Here are the top 5 most-viewed alopecia content in 2025.

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial. Alopecia ...

A researcher has hailed "exciting" results from a study into a treatment for the hair loss condition alopecia areata. A relatively common condition, alopecia areata is thought to affect 1 in every 500 ...

The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...

Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...

Apropos of absolutely nothing, scientists announced this week that a common arthritis medication appears to help alopecia patients regrow their hair — a significant potential treatment for a ...

This article was reviewed by Knox Beasley, MD. Retrograde alopecia is a form of hair loss characterized by the gradual thinning or recession of hair at the nape of the neck or the sides of the scalp.

A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug. The study is based on Phase 3 clinical trials using ...